UAA
UAA
Under Armour, Inc.
$4.88
+2.52% 2026-10-20
Consumer DiscretionaryS&P 600
UAASPY
1W
-0.4%
1M
+0.0%
3M
-33.8%
6M
-27.5%
YTD
-1.8%
1Y
+3.2%
Live chart
Loading live chart…
Grades vs sector
Momentum48th pct in sectorC
Momentum
48th pct in sector
12-1 return: -3.3%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth18th pct in sectorD
Growth
18th pct in sector
Revenue growth (YoY): -3.2%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value15th pct in sectorD-
Value
15th pct in sector
Forward E/P: 4.1% · EBITDA/EV: 5.7%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability3rd pct in sectorF
Profitability
3rd pct in sector
Profit margin: -10.0% · Return on equity: -29.8%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsNextdoor Holdings Stock And 2 More Penny Stocks To Watch
Simply Wall St. · Oct 18
Nike Stock Has Been Dismal. Why It’s Time to Be Bullish.
Barrons.com · Oct 17
Emergent BioSolutions stock falls as CFO plans retirement
Investing.com · Oct 16
Consumer Discretionary - Apparel and Accessories Stocks Q2 Results: Benchmarking Under Armour (NYSE:UAA)
StockStory · Oct 15
UNDER ARMOUR ANNOUNCES DATE FOR SECOND QUARTER FISCAL 2027 EARNINGS CONFERENCE CALL
PR Newswire · Oct 14
Key stats
Market cap$2.1B
P/E (trailing)–
P/E (forward)25.3
52-week range4.13 – 8.15
Revenue growth (YoY, latest qtr)-3.2%
Dividend yield0.00%
Analyst consensusHold (18)
Mean price target$6.36 (+30%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
No cash-flow valuation
Model read-out from the numbers below, not advice. Score -1 (DCF counts double).
▼Forward P/E vs sector25.3x vs median 13.4x
▼Piotroski F-score3/9
•Altman Z2.0 (grey)
▲Analyst target+30% (18 analysts)
Discounted cash flow
Trailing free cash flow is negative or missing, so a cash-flow DCF isn't meaningful by default. You can enter your own assumptions below.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Trailing free cash flow is zero or negative, so there's no growth rate to solve for. The price is betting on a turnaround to positive cash flow.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.62 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Consumer Discretionary
P/E (trailing)
sector median 17.7×
–Forward P/E
pricier
sector median 13.4× · 90th pct
25.3×pricier
EV / EBITDA
sector median 11.3×
–Price / sales
cheaper
sector median 1.2× · 19th pct
0.4×cheaper
Price / book
cheaper
sector median 2.8× · 30th pct
1.5×cheaper
FCF yield
pricier
sector median 6.6% · 4th pct
-3.9%pricier
Forward EPS $0.19 vs trailing $-1.15. Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
46.8%
Operating margin
-2.4%
FCF margin
-1.6%
Net margin
-10.0%
Return on equity
-34.5%
Return on invested capital
-5.8%
Net debt / EBITDA
–
Current ratio
1.8×
Interest cover
-1.9×
Cash conversion (OCF/NI)
–
Piotroski F-score 3/9 · last two fiscal years
✗ Positive net income✗ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved
Altman Z-score 2.0 (grey zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$6
+30%
Analysts
18
Hold
Range
$4–$12
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $5.0B | $-495.6M | $-162.2M |
| 2025 | $5.2B | $-201.3M | $-228.0M |
| 2024 | $5.7B | $232.0M | $203.6M |
| 2023 | $5.9B | $374.5M | $-198.0M |
| 2021 | $5.7B | $351.0M | $594.5M |
| 2020 | $4.5B | $-549.2M | $120.6M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR -5.6%.
Earnings
Next report: 2026-11-06 · before open · EPS est -0.01
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-07 | 0.02 | 0.05 | +192.6% |
| 2026-05-12 | -0.02 | -0.03 | -67.6% |
| 2026-02-06 | -0.01 | 0.09 | +721.1% |
| 2025-11-06 | 0.02 | 0.04 | +65.8% |
| 2025-08-08 | 0.03 | 0.02 | -21.6% |
| 2025-05-13 | -0.08 | -0.08 | -0.6% |
| 2025-02-06 | 0.03 | 0.08 | +139.0% |
| 2024-11-07 | 0.19 | 0.30 | +54.8% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $1.1B | -3.2% |
| 2026-03-31 | $1.2B | – |
| 2025-12-31 | $1.3B | – |
| 2025-09-30 | $1.3B | – |
| 2025-06-30 | $1.1B | – |
Analyst actions
Barclays
PT $5
2026-08-11 · down
Equal-Weight → UnderweightPT $5
UBS
PT $9
2026-08-10 · main
Buy → BuyPT $9
Truist Securities
PT $6
2026-08-10 · main
Hold → HoldPT $6
UBS
PT $10
2026-05-14 · main
Buy → BuyPT $10
Citigroup
PT $5
2026-05-13 · main
Sell → SellPT $5
BNP Paribas
PT $5
2026-05-13 · main
Neutral → NeutralPT $5
Insider trades
Taleghani Reza
$100.2K
Chief Financial Officer · 2026-08-11
BUY$100.2K
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 18:09:17 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.